市场调查报告书
商品编码
1410790
美容注射市场:市场规模(按细分市场)、份额、法律法规、报销、程序、预测(截至2033年)Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
注射美容是指将凝胶状物质注射到皮下以恢復更年轻的外观。这可以透过增加凹陷的脸颊和太阳穴的体积、减少鼻子和嘴巴周围的皱纹(木偶纹或微笑纹)、丰满嘴唇和强调面部轮廓来实现。美容注射变得越来越流行,因为它们是非手术且非侵入性的。
此外,可以在有限的恢復时间内快速取得成功的结果。随着美容注射剂市场的成长,外科医生可用的注射填充剂的数量和类型不断增加。
该报告深入探讨了全球注射美容市场,包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。
Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Aesthetic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Aesthetic Injectables market for the year 2020 and beyond. Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. This is achieved by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. Aesthetic Injectables are rising in popularity, due to the non-surgical and non-invasive nature of these procedures.
In addition, successful outcomes are achieved quickly with limited recovery time. As the aesthetic injectables market grows, the number and variety of injectable fillers available to surgeons is increasing.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Aesthetic Injectables and evolving competitive landscape -
Global, Regional, and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: AbbVie Inc, Galderma SA, Merz Pharma GmbH & Co KgaA, Huadong Medicine Co Ltd, Teoxane SA, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable